Close
Robotic Factories Supercharge Industrial Digitalization as Electronic Makers Adopt NVIDIA AI and Omniverse Jun 2, 2024 08:44AM

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced that major Taiwanese electronics makers are using the company’s technology to transform their factories into more autonomous facilities with a new reference workflow. The workflow combines NVIDIA Metropolis vision AI, NVIDIA Omniverse™ physically based rendering and simulation, and NVIDIA Isaac™ AI robot development and deployment.

By using the workflow to build digital twins... (continue reading...)


Bio-Thera Solutions Presents Clinical Data for BAT8006 (Folate Receptor-alpha-ADC) at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting Jun 2, 2024 08:42AM

GUANGZHOU, China, June 2, 2024 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, will present a poster at the 2024 ASCO Annual Meeting entitled "Phase 1 study of BAT8006, a folate receptor α antibody drug conjugate with strong bystander effect, in subjects with advanced solid tumors," that highlights clinical data for the potential best-in-class efficacy... (continue reading...)


NVIDIA Brings AI Assistants to Life With GeForce RTX AI PCs Jun 2, 2024 08:41AM

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced new NVIDIA RTX™ technology to power AI assistants and digital humans running on new GeForce RTX™ AI laptops.

NVIDIA unveiled Project G-Assist — an RTX-powered AI assistant technology demo that provides context-aware help for PC games and apps. The Project G-Assist tech demo debuted with ARK: Survival Ascended from Studio Wildcard. NVIDIA also introduced the first PC-based... (continue reading...)


Computer Industry Joins NVIDIA to Build AI Factories and Data Centers for the Next Industrial Revolution Jun 2, 2024 08:35AM
  • Top Computer Manufacturers Unveil Array of Blackwell-Powered Systems Featuring Grace CPUs, NVIDIA Networking and Infrastructure
  • Broad Portfolios Encompass Cloud, On-Premises, Embedded and Edge AI Systems
  • Offerings Range From Single to Multi-GPUs, x86 to Grace, Air to Liquid Cooling

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA and the world’s top computer manufacturers today unveiled an array of NVIDIA Blackwell architecture-powered systems... (continue reading...)


NVIDIA Supercharges Ethernet Networking for Generative AI Jun 2, 2024 08:32AM

TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced widespread adoption of the NVIDIA Spectrum™-X Ethernet networking platform as well as an accelerated product release schedule.

CoreWeave, GMO Internet Group, Lambda, Scaleway, STPX Global and Yotta are among the first AI cloud service providers embracing NVIDIA Spectrum-X to bring extreme networking performance to their AI infrastructures. Additionally, several NVIDIA... (continue reading...)


More Press Releases

View Older Stories

Jun 2, 2024 08:30AM Trend Micro to Secure AI-Enabled Private Data Centers Worldwide
Jun 2, 2024 08:30AM Denodo Opens ME Regional Head Office in Kingdom of Saudi Arabia to Meet Growing Demand for Data Management and AI
Jun 2, 2024 08:30AM Vention to democratize industrial automation using NVIDIA AI technologies
Jun 2, 2024 08:30AM Denodo Integrates NVIDIA NIM Inference Microservices to Accelerate and Optimize AI Capabilities for Enterprises
Jun 2, 2024 08:23AM GDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that GoodRx Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
Jun 2, 2024 08:13AM NVIDIA NIM Revolutionizes Model Deployment, Now Available to Transform World’s Millions of Developers Into Generative AI Developers
Jun 2, 2024 08:11AM NVIDIA Releases Digital Human Microservices, Paving Way for Future of Generative AI Avatars
Jun 2, 2024 08:05AM IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo
Jun 2, 2024 08:00AM ENHERTU® Demonstrated a Median Progression-Free Survival of 13.2 Months in HR Positive, HER2 Low and HER2 Ultralow Metastatic Breast Cancer Following One or More Lines of Endocrine Therapy
Jun 2, 2024 08:00AM ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lin
Jun 2, 2024 08:00AM OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma
Jun 2, 2024 08:00AM Massive Bio and Mika Health Combine AI and Next-Generation Sequencing Biomarker Testing to Empower Cancer Patients On Treatment and Those Searching for and Participating in Clinical Trials in the Unit
Jun 2, 2024 08:00AM Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
Jun 2, 2024 08:00AM Intellia Therapeutics Announces Positive Long-Term Data from Ongoing Phase 1 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)
Jun 2, 2024 08:00AM William Miller Spearheads Launch of Pioneering OkayCoin Staking Protocol
Jun 2, 2024 08:00AM CryptoHeap Launches Comprehensive Strategy for Crypto Staking Amidst Market Fluctuations
Jun 2, 2024 07:00AM RentFinder.ai Sets New Standards in Rental Estimates, Achieves 250% Surge in Usage
Jun 2, 2024 07:00AM Fast Guard Service Releases Guide to Choosing the Best Fire Watch Service
Jun 2, 2024 07:00AM June Joy at Juicy Stakes Casino
Jun 2, 2024 07:34AM Accelerate Your Establishment Forward By Implementing These Simple Corporate Hacks
Jun 2, 2024 07:34AM Exploring The Main Aspects To Consider When Eradicating Pesky Pests From Your Home
Jun 2, 2024 06:18AM Sunvozertinib's Global Pivotal WU-KONG1B Study Meets Primary Endpoint in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Jun 2, 2024 06:37AM Top 10 Compelling Reasons Why Your Kids Should Have Regular School Physicals
Jun 2, 2024 06:23AM Odyssey Capital participated in the Washington D.C. Blockchain Summit, proposing the establishment of a Global Special Assets Alliance Fund initiative.
Jun 2, 2024 06:15AM Are Ruby Gemstones Worth Investing In?
Jun 2, 2024 04:00AM BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment
Jun 2, 2024 03:39AM Capsucup: Where Quality and Sustainability Meet in Italian Espresso
Jun 2, 2024 03:23AM Leading Contractor Marketing Agency Webrunner Media Broadens Service Portfolio
Jun 2, 2024 03:21AM Xfive Recognized as a Clutch Global Leader for Spring 2024
Jun 2, 2024 02:00AM ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth
Jun 2, 2024 01:13AM Innovent Announces Taletrectinib（ROS1 Inhibitor）Updated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting
Jun 2, 2024 12:57AM Eyes Defined Introduces 3D Images to Revolutionize Eyelid Surgery Planning
Jun 1, 2024 11:56PM Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in Patients with NSCLC
Jun 1, 2024 09:00PM BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm
Jun 1, 2024 08:25PM Jacobio Pharma Presents SHP2 Plus KRAS G12C Data at ASCO
Jun 1, 2024 08:24PM OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaka' at the UEFA Champions League Final 2024
Jun 1, 2024 08:17PM CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC
Jun 1, 2024 08:15PM OPPO Scores Unforgettable Experiences with Global Brand Ambassador Kaká at the UEFA Champions League Final 2024
Jun 1, 2024 08:15PM Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever
Jun 1, 2024 08:00PM Innovent Presents at the 2024 ASCO Annual Meeting on Clinical Data of anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Pancreatic Cancer or Biliary Tract Cancer
Jun 1, 2024 08:00PM Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and Reported at 2024 ASCO Annual Meeting
Jun 1, 2024 08:00PM Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting
Jun 1, 2024 07:13PM GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a La
Jun 1, 2024 06:09PM LENNY KRAVITZ ROCKS OUT AT THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI®
Jun 1, 2024 05:52PM Sun Bum Makes SPF Waves in Miami with its Largest Ever Beach Hangout for Skin Cancer Awareness Month
Jun 1, 2024 05:10PM National Skills Champions are Honoured at the Skills Canada National Competition 2024, in Québec
Jun 1, 2024 04:30PM Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation
Jun 1, 2024 03:40PM BIOHACKING CONFERENCE ANNOUNCES STEMREGENⓇ WILL RETURN AS TITLE SPONSOR FOR 2025
Jun 1, 2024 03:00PM First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process
Jun 1, 2024 03:00PM Immunofoco Biotech to Unveil Solid Tumor CAR-T Programs Clinical Trial Data at 2024 ASCO Meeting
View Older Stories